Longitudinal On-treatment Circulating Tumor DNA as A Biomarker for Real-Time Dynamic Risk Monitoring in Cancer Patients: the EP-SEASON Study

Study-level data are deposited in this dataset. Any additional information required to reanalyze the data is available from the lead contact upon request.